-
Chief Executive Officer Of Moderna Makes $7.3M Sale
Friday, October 1, 2021 - 11:06am | 394Read More...Stephane Bancel, Chief Executive Officer at Moderna (NASDAQ:MRNA), made a large insider sell on September 30, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Bancel sold 23,000 shares of Moderna at prices...
-
Notable Moderna Insider Makes $8.20 Million Sale
Friday, September 10, 2021 - 5:04pm | 388Read More...Stephane Bancel, Chief Executive Officer at Moderna (NASDAQ:MRNA), made a large insider sell on September 9, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Bancel sold 19,000 shares of Moderna at a price of $...
-
What's Going On With Moderna's Stock Today?
Monday, August 9, 2021 - 10:52am | 219Read More...Moderna Inc (NASDAQ: MRNA) is trading higher Monday as growing COVID-19 concerns lift vaccine makers. The company's COVID-19 vaccine was also granted provisional registration by the Australian Therapeutic Goods Administration. Moderna announced that the TGA granted provisional...
-
What's Going On With Moderna's Stock Today?
Wednesday, August 4, 2021 - 1:09pm | 178Read More...Moderna Inc (NASDAQ: MRNA) is trading higher Wednesday on continued strength following the company's announcement that it received FDA Fast Track designation for mRNA-1345. Moderna's mRNA-1345 is a investigational single-dose mRNA vaccine that fights against respiratory...
-
Moderna Hires Ogilvy Health CEO Kate Cronin As Chief Brand Officer To Build On COVID-19 Vaccine Momentum
Monday, June 28, 2021 - 5:09pm | 401Read More...COVID-19 vaccine company Moderna, Inc. (NASDAQ: MRNA) announced Monday a new hire to enhance its brand appeal. What Happened: Moderna said Kate Cronin will join the company as chief brand officer, effective July 12. Cronin will also serve on the company's executive committee and report to CEO...
-
11 Biopharma CEOs To Follow On Twitter
Thursday, August 18, 2016 - 10:52am | 613Read More...Twitter Inc (NYSE: TWTR) can be an extremely useful and tradable tool for investors, but only if you follow the right people. Here’s a look at 11 biotech and pharmaceutical company CEOs that have the potential for market-moving tweets. 1. Brent Saunders - @brentlsaunders Saunders is...
